期刊文献+

PEG化壳聚糖质粒纳米粒的制备及其转染的研究 被引量:1

Preparation and transfection of PEG chitosan nanoparticles as gene vector
原文传递
导出
摘要 目的制备壳聚糖纳米粒并构建聚乙二醇(PEG)化壳聚糖质粒纳米粒,研究其对大鼠主动脉内皮细胞的转染能力及细胞毒性。方法采用离子交联法制备壳聚糖纳米粒,应用喷金扫描电子显微镜检测壳聚糖纳米粒粒径的分布与形态;通过静电吸附作用连接上pGenesil-1质粒(报告基因);对壳聚糖质粒纳米粒进行PEG化的修饰;应用PEG化壳聚糖质粒纳米粒转染大鼠主动脉内皮细胞;采用噻唑蓝(MTT)法测定壳聚糖纳米粒对细胞的毒性作用。结果喷金扫描电镜检测显示壳聚糖纳米粒呈均匀分散的球形颗粒,平均直径为5nm;PEG化壳聚糖质粒纳米粒能转染大鼠主动脉内皮细胞;MTT结果显示壳聚糖纳米粒对细胞无毒性作用;壳聚糖质粒纳米粒对内皮细胞的转染效率为26%,PEG修饰壳聚糖质粒纳米粒转染细胞,转染率为63.4%。结论对壳聚糖质粒纳米粒进行化学修饰不仅能提高其转染效率,且对细胞无毒性作用。 Objective To prepare chitosan/plamid nanoparticle(CS-NP) and assess its cytotoxicity and transgenic efficacy to endothelial cells from rat aorta. Methods Ion exchange method was used to prepare CS-NP. Diametric distribution and form of CS-NP were tested by puff gold scanning electron microscope (SEM). Connection of pGenesil-1 with CS-NP was accomplished by electrostatic adsorption and CS-NP was chemically modified by PEG. The PEG CS-NP was then used to transfeet the endothelial cell from rat aorta. The toxic effects to endothelial cell were detected by MTT method. Results The results of SEM showed that CS-NP were of spheri- cal shape and well-dispersed, with average diameter of 5 nm. MTT test showed that PEG CS-NP was nontoxic to the aortic vascular cells and mediated a significantly higher transgene expression(63.4%) than CS-NP(26%). Conclusion The PEG CS-NP not only can improve the transfection efficiency, but also have no toxic effects on aortic vascular cells.
出处 《国际生物医学工程杂志》 CAS 北大核心 2009年第3期146-148,I0001,共4页 International Journal of Biomedical Engineering
基金 山西省回国留学人员科研资助项目(2007重点项目-5)
关键词 壳聚糖 纳米粒 质粒 结合 转染 Chitosan Nanoparticles Plasmid Combine Trasfection
  • 相关文献

参考文献4

二级参考文献21

  • 1宗莉,陈伶俐,张淑芸,杨晓容,朱家壁.壳聚糖纳米粒作为基因载体的研究:制备,特征和对DNA的保护[J].中国药科大学学报,2005,36(6):526-530. 被引量:16
  • 2Janes KA, Freseneau MP, Marazuela, et al. Chitosan nanoparticles as delivery systems for doxorubicin [J]. Control Release, 2001, 73(2-3): 255-267.
  • 3Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles[J]. Int J Pharm, 2003, 250(1): 215-226.
  • 4Anas El Aneed.An overview of current delivery systems in cancer gene therapy[J].Journal of Controlled Release ,2004,94:1
  • 5Curotto E,Aros F.Quantitative determination of chitosan and the percentage of free amino group[J].Analytical Biochemistry,1993, 211(2):240
  • 6Penketh,Shyam K,Santorelli AC.Fluorometric assay for determination of DNA-DNA cross-links utilizing Hoechst 33258 at neutral pH values[J].Analytical Biochemistry,1997, 252:213
  • 7Tang MX,Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes[J]. Gene Therapy, 1994:823-832.
  • 8Bazile D, Prud'homme C, Bassoullet MT, et al, Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system[ J]. J Pharm Sci, 1995,84:493-498.
  • 9Biessen EA, Vietsch H, Rump ET, et al. Targeted delivery of oligoeoxynucleotides to parenchymal liver cells in vivo [ J].Biochem J, 1999,340:783-792.
  • 10Vilaa A,Sáncheza A,Janes K,et al.Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice[J].Eur J Pharm Biopharm,2004,57:123-131.

共引文献31

同被引文献15

  • 1Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodefieient patients[J]. Science, 1995,270(5235): 470-475.
  • 2Jafari M, Soltani M, Naahidi S, et al. Nonviral approach for targeted nucleic acid delivery[J]. Curr Med Chcm, 2012, 19(2): 197-208.
  • 3Ishikawa K, Tilemann L, Fish K, et al. Gene delivery methods in cardiac gene therapy[J]. J Gene Med, 2011, 13(10): 566-572.
  • 4Heilbronn R, Weger S. Viral vectors for gene transfer: current status of gene therapeutics[J]. Handb Exp Pharmacol, 2010, 197(2):143-170.
  • 5Marshall E. Gene therapy on trial[J]. Science, 2000, 288(5468): 951- 957.
  • 6Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia[J]. Gene Ther, 2003, 10(4): 285-291.
  • 7Knowles MR, Hohneker KW, Zhou Zhao-qing, et at. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis[J]. N Engl J Med, 1995, 333 (13): 823-831.
  • 8Liu Chun-xi, Zhang Na. Nanoparticles in gene therapy principles, prospects, and challenges[J]. ProgMol Biol Transl Sei, 2011, 104: 509-562.
  • 9Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector- mediated gene delivery[J]. Biotechnol J, 2009, 4(11): 1559-1572.
  • 10Wang Jun, Gao SJ, Zhang Peng-chi, et al. Polyphosphoramidate gene carriers: effect of charge group on gene transfer efficiency[J]. Gene Ther, 2004, 11(12): 1001-1010.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部